comparemela.com

Latest Breaking News On - Jaimer merch - Page 1 : comparemela.com

Dr Merchán on the Future Treatment of Advanced RCC

Dr Merchán on the Future Treatment of Advanced RCC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Jaimer-merch
University-of-miami-health-system
Clinical-trials-program
Department-of-medicine
Sylvester-comprehensive-cancer-center
Clinical-oncology-research-program
Division-of-medical-oncology
Medical-oncology
Trials-program
Miami-health-system

Dr Merchán on the Role of Immunotherapy and TKI Combinations in RCC

Jaime R. Merchán, MD, discusses the current roles for immunotherapy and TKIs in patients with renal cell carcinoma.

Miami
Florida
United-states
Jaimer-merch
Department-of-medicine
Clinical-trials-program
Clinical-oncology-research-program
Sylvester-comprehensive-cancer-center
University-of-miami-miller-school-medicine
Division-of-medical-oncology
Trials-program

Dr Bilusic on the Non-ccRCC Treatment Armamentarium

Marijo Bilusic, MD, PhD, discusses combination regimens under investigation for patients with non–clear cell renal cell carcinoma.

Miami
Florida
United-states
Jaimer-merch
University-of-miami-miller-school-medicine
Sylvester-comprehensive-cancer-center
Marijo-bilusic
Miami-miller-school
Science-summit
D
Phd

Dr Merchan on Key Data Supporting Pembrolizumab-Based Regimens in Advanced RCC

Jaime R. Merchán, MD, discusses the role of pembrolizumab plus axitinib or lenvatinib in previously untreated advanced renal cell carcinoma.

Jaimer-merch
Division-of-medical-oncology
Department-of-medicine
Clinical-trials-program
University-of-miami-health-system
Sylvester-comprehensive-cancer-center
Clinical-oncology-research-program
Medical-oncology
Trials-program
Miami-health-system
Cancers-symposium

Non–Clear Cell RCC Subtypes Require Individualized Approach to Treatment Selection

Jaime R. Merchán, MD, spotlights case studies of patients with rare non-ccRCC histologies, discussing their clinical presentation, recent data on immunotherapy and targeted treatment options for the management of these disease subtypes, and patient outcomes on these therapies.

University-of-miami
Florida
United-states
Jaimer-merch
Department-of-medicine
National-cancer-institute
University-of-miami-health-system
National-comprehensive-cancer-network
Division-of-medical-oncology
Clinical-oncology-research-program
Science-summit

vimarsana © 2020. All Rights Reserved.